In many cortical regions the AD samples expressed higher levels of GFAP than the LBC1936 case (Fig. 6b) as expected from our stereological burden counts (Fig. 4), however in BA46 and the hippocampus the levels were higher in the LBC1936 sample. This evidence concerns the gene GFAP and Alzheimer disease.